Churchill Capital Corp X to Transfer Listing to NYSE Post-Infleqtion Merger
summarizeSummary
Churchill Capital Corp X announced its intent to transfer its stock and warrant listings from Nasdaq to the NYSE, effective February 17, 2026, following the completion of its merger with Infleqtion.
check_boxKey Events
-
Listing Transfer to NYSE
Churchill Capital Corp X will transfer the listing of its Class A ordinary shares and public warrants from Nasdaq to the New York Stock Exchange (NYSE) upon completion of the Infleqtion business combination.
-
Post-Merger Ticker Symbols
Following the business combination, the combined company's common stock and warrants are expected to trade on the NYSE under the symbols "INFQ" and "INFQ WS", respectively.
-
Effective Dates
Trading on Nasdaq will cease at market close on February 13, 2026, with trading on the NYSE commencing at market open on February 17, 2026.
-
Cayman to Delaware Re-domestication
In connection with the business combination, Churchill X will transfer its registration by way of continuation from the Cayman Islands to the State of Delaware.
auto_awesomeAnalysis
This 8-K details the planned transfer of Churchill Capital Corp X's securities listing from Nasdaq to the New York Stock Exchange (NYSE) following the completion of its business combination with Infleqtion. This move, contingent on the merger's approval, provides crucial logistical information for investors regarding the trading venue and new ticker symbols ("INFQ" and "INFQ WS") for the combined entity. The transfer is a standard procedural step for SPACs completing a de-SPAC transaction and is generally viewed as a neutral to slightly positive development, indicating the finalization of the merger process. This follows the recent filings regarding the S-4 effectiveness and the upcoming shareholder vote on February 12, 2026.
At the time of this filing, CCCX was trading at $14.49 on NASDAQ in the Technology sector, with a market capitalization of approximately $745.9M. The 52-week trading range was $10.03 to $27.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.